Dan‐ni Ren
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Wnt/β-catenin signaling in development and cancer
- Cancer-related gene regulation
- RNA modifications and cancer
Papers in
-
- Signaling Pathways in Disease 5
- Wnt/β-catenin signaling in development and cancer 5
- Cancer-related gene regulation 3
-
- Cardiac Fibrosis and Remodeling 6
- Co-authors
- Da Wo (20 shared papers)Weidong Zhu (18 shared papers)Jingxiao Chen (14 shared papers)Hongwei Yan (5 shared papers)Jun Peng (8 shared papers)Jun Peng (5 shared papers)Jianhua Yang (2 shared papers)Yihan Chen (2 shared papers)
- Journals
- Biomedicine & Pharmacotherapy (3 papers)Journal of Cellular and Molecular Medicine (3 papers)Clinical Cancer Research (1 paper)Phytotherapy Research (1 paper)FEBS Journal (1 paper)
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Dan‐ni Ren
19 papers receiving 269 citations
Peers
Comparison fields: 5 of 65
- Cancer Research 43
- Molecular Biology 174
- Complementary and alternative medicine 14
- Oncology 45
- Cardiology and Cardiovascular Medicine 31
Countries citing papers authored by Dan‐ni Ren
This map shows the geographic impact of Dan‐ni Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan‐ni Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan‐ni Ren more than expected).
Fields of papers citing papers by Dan‐ni Ren
This network shows the impact of papers produced by Dan‐ni Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan‐ni Ren. The network helps show where Dan‐ni Ren may publish in the future.
Co-authors
The 25 scholars most cited alongside Dan‐ni Ren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 55 | |
| 2 | 2014 | 31 | |
| 3 | 2019 | 30 | |
| 4 | 2023 | 24 | |
| 5 | 2019 | 22 | |
| 6 | 2023 | 18 | |
| 7 | 2021 | 14 | |
| 8 | 2024 | 11 | |
| 9 | 2023 | 9 | |
| 10 | 2023 | 8 | |
| 11 | 2022 | 8 | |
| 12 | 2020 | 8 | |
| 13 | 2023 | 7 | |
| 14 | 2021 | 7 | |
| 15 | 2021 | 7 | |
| 16 | 2022 | 5 | |
| 17 | 2023 | 5 | |
| 18 | 2025 | 2 | |
| 19 | 2025 | 1 | |
| 20 | 2025 | 0 |
About Dan‐ni Ren
Dan‐ni Ren is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Cancer Research, Oncology and Endocrinology, Diabetes and Metabolism, having authored 21 papers that have together received 272 indexed citations. Recurring topics across this work include Cardiac Fibrosis and Remodeling (6 papers), Signaling Pathways in Disease (5 papers), Wnt/β-catenin signaling in development and cancer (5 papers), Cancer-related gene regulation (3 papers), NF-κB Signaling Pathways (3 papers), Peptidase Inhibition and Analysis (2 papers), Pancreatic function and diabetes (1 paper) and Diet, Metabolism, and Disease (1 paper). The work is most often cited by research in Cancer Research (43 citations), Molecular Biology (174 citations), Complementary and alternative medicine (14 citations), Oncology (45 citations) and Cardiology and Cardiovascular Medicine (31 citations). Dan‐ni Ren has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Da Wo, Weidong Zhu, Jingxiao Chen, Hongwei Yan, Jun Peng, Jun Peng, Jianhua Yang, Yihan Chen, Shangfeng Liu and Yan Yin. Their work appears in journals such as Biomedicine & Pharmacotherapy, Journal of Cellular and Molecular Medicine, Clinical Cancer Research, Phytotherapy Research and FEBS Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.